Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers (2023)
Attributed to:
Molecular mapping of SARS-CoV2 and the host response with multiomics mass spectrometry to stratify disease outcomes
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ijms241814371
PubMed Identifier: 37762673
Publication URI: http://europepmc.org/abstract/MED/37762673
Type: Journal Article/Review
Parent Publication: International Journal of Molecular Sciences
Issue: 18